Evidence map›Paper›PMID 26923185›Full record

ArticleBMC infectious diseases2016

Is Zimbabwe ready to transition from anonymous unlinked sero-surveillance to using prevention of mother to child transmission of HIV (PMTCT) program data for HIV surveillance?: results of PMTCT utility study, 2012.

E Gonese, A Mushavi, M Mungati, M Mhangara, J Dzangare, O Mugurungi, J Dee, P H Kilmarx, G Shambira, M T Tshimanga and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

E GoneseCenters for Disease Control and Prevention, 38 Nelson Mandela Rd, Box 3088, Harare, Zimbabwe. egonese@cdc.gov.
A MushaviMinistry of Health and Child Care Zimbabwe, Mukwati Building, Corner Livingstone/Fifth Street, Harare, Zimbabwe. mushavia@yahoo.co.uk.
M MungatiMinistry of Health and Child Care Zimbabwe, Mukwati Building, Corner Livingstone/Fifth Street, Harare, Zimbabwe. mungatim@yahoo.com.
M MhangaraMinistry of Health and Child Care Zimbabwe, Mukwati Building, Corner Livingstone/Fifth Street, Harare, Zimbabwe. mutsa.mhangara@gmail.com.
J DzangareMinistry of Health and Child Care Zimbabwe, Mukwati Building, Corner Livingstone/Fifth Street, Harare, Zimbabwe. janet.dzangare@gmail.com.
O MugurungiMinistry of Health and Child Care Zimbabwe, Mukwati Building, Corner Livingstone/Fifth Street, Harare, Zimbabwe. atp.director@ymail.com.
J DeeCenters for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329-4027, USA. idi0@cdc.gov.
P H KilmarxNational Institute of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA. peter.kilmarx@nih.gov.
G ShambiraDepartment of Community Medicine, University of Zimbabwe, Parirenyatwa Hospital, Mazoe Street, Harare, Zimbabwe. gshambira@yahoo.com.
M T TshimangaDepartment of Community Medicine, University of Zimbabwe, Parirenyatwa Hospital, Mazoe Street, Harare, Zimbabwe. mufutatshimanga@gmail.com.
J HargroveSouth Africa Centre for Epidemiological Modelling and Analysis, Stellenbosch University, 19 Jonkershoek Road, Stellenbosch, 7602, South Africa. jhargrove@sun.ac.za.
Ministry of Health and Child Welfare · ZWParirenyatwa Hospital · ZWCenters for Disease Control and Prevention · USStellenbosch University · ZA

Funding

CGH CDC HHS U2G GH000315
6 · The paper itself

Abstract

backgroundPrevention of mother-to-child transmission of HIV (PMTCT) programs collect socio-demographic and HIV testing information similar to that collected by unlinked anonymous testing sero-surveillance (UAT) in antenatal settings. Zimbabwe evaluated the utility of PMTCT data in replacing UAT.

methodsA UAT dataset was created by capturing socio-demographic, testing practices from the woman's booking-card and testing remnant blood at a laboratory from 1 June to 30 September 2012. PMTCT data were collected retrospectively from ANC registers. UAT and PMTCT data were linked by bar-code labels that were temporarily affixed to the ANC register. A questionnaire was used to obtain facility-level data at 53 sites.

resultsPooled HIV prevalence was 15.8 % (95 % CI 15.3-16.4) among 17,349 women sampled by UAT, and 16.3 % (95 % CI 15.8 %-16.9 %) among 17,150 women in PMTCT datasets for 53 sites. Pooled national percent-positive agreement (PPA) was 91.2 %, and percent-negative agreement (PNA) was 98.7 % for 16,782 women with matched UAT and PMTCT data. Based on UAT methods, overall median prevalence was 12.9 % (Range 4.0 %-19.4 %) among acceptors and refusers of HIV test in PMTCT compared to 12.5 % ((Range 3.4 %-19.5 %) among acceptors in ANC registers. There were variations in prevalence by site.

conclusionAlthough, there is no statistical difference between pooled HIV prevalence in UAT compared to PMTCT program, the overall PPA of 91.2 % and PNA of 98.7 % fall below World Health Organisation (WHO) benchmarks of 97.6 % and 99.6 % respectively. Zimbabwe will need to strengthen quality assurance (QA) of rapid HIV testing and data collection practices. Sites with good performance should be prioritised for transitioning.

Indexed as

FemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousPrevalencePublic Health SurveillanceRetrospective StudiesZimbabwe

Identifiers

PMID26923185
PMCPMC4770682
OpenAlexW2277563610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.